About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Urology
›
top-articles
Division of Urology
209
(top 1%)
papers
9.7K
(top 1%)
citations
50
(top 1%)
h
-index
95
(top 1%)
g
-index
225
all documents
10.1K
doc citations
1.9K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring
New England Journal of Medicine
2004
650
2
BCG immunotherapy of bladder cancer: 20 years on
Lancet, The
1999
417
3
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
Journal of Urology
2011
408
4
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
European Urology
2009
376
5
Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors
Urology
2010
356
6
Urine
TMPRSS2:ERG
Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Science Translational Medicine
2011
313
7
IS LOW SERUM FREE TESTOSTERONE A MARKER FOR HIGH GRADE PROSTATE CANCER?
Journal of Urology
2000
290
8
Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
European Urology
2015
282
9
Minimally Important Difference for the Expanded Prostate Cancer Index Composite Short Form
Urology
2015
241
10
High Failure Rate of Indwelling Ureteral Stents in Patients with Extrinsic Obstruction: Experience at 2 Institutions
Journal of Urology
1989
214
11
Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less
Urology
2006
200
12
Occult Prostate Cancer in Men With Low Serum Testosterone Levels
JAMA - Journal of the American Medical Association
1996
192
13
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Clinical Cancer Research
2009
184
14
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
Urologic Oncology: Seminars and Original Investigations
2013
181
15
Testosterone Replacement Therapy in Hypogonadal Men at High Risk for Prostate Cancer: Results of 1 Year of Treatment in Men With Prostatic Intraepithelial Neoplasia
Journal of Urology
2003
173
16
Results of Inferior Vena Cava Resection for Renal Cell Carcinoma
Journal of Urology
1981
154
17
Expanded Prostate Cancer Index Composite for Clinical Practice: Development and Validation of a Practical Health Related Quality of Life Instrument for Use in the Routine Clinical Care of Patients With Prostate Cancer
Journal of Urology
2011
152
18
Experimental Cryptorchidism Induces Testicular Germ Cell Apoptosis by p53-Dependent and -Independent Pathways In Mice
Biology of Reproduction
1998
136
19
MR classification of renal masses with pathologic correlation
European Radiology
2008
136
20
Testosterone Therapy in Men With Untreated Prostate Cancer
Journal of Urology
2011
134
21
Heat stress causes testicular germ cell apoptosis in adult mice
Journal of Andrology
1997
134
22
p53-Mediated Germ Cell Quality Control in Spermatogenesis
Developmental Biology
1998
129
23
Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
British Journal of Cancer
2009
121
24
Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes
Infection and Immunity
1994
111
25
[-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study
Journal of Urology
2008
98
26
p53 and Fas Are Sequential Mechanisms of Testicular Germ Cell Apoptosis
Journal of Andrology
2002
97
27
Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens
Andrologia
2014
88
28
Original Articles: Testis Cancer: A Review of Scrotal Violation in Testicular Cancer: Is Adjuvant Local Therapy Necessary?
Journal of Urology
1995
87
29
IFN-α 2B Enhances Th1 Cytokine Responses in Bladder Cancer Patients Receiving
Mycobacterium bovis
Bacillus Calmette-Guérin Immunotherapy
Journal of Immunology
1999
87
30
Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
Journal of Immunology
1997
86
31
Prospective Study of Determinants and Outcomes of Deferred Treatment or Watchful Waiting Among Men With Prostate Cancer in a Nationwide Cohort
Journal of Clinical Oncology
2009
83
32
Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer
Cancer
2014
82
33
Is low serum free testosterone a marker for high grade prostate cancer?
Journal of Urology
2000
80
34
IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy
Journal of Immunology
1999
79
35
Male impotence
Lancet, The
1999
75
36
Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin
Biochemical and Biophysical Research Communications
2003
75
37
Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin
Journal of Immunology
1999
68
38
Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state
Journal of Immunology
1997
66
39
Congenital anomalies of the vas deferens, epididymis, and seminal vesicles
Urology
1997
64
40
Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir
Journal of Reproductive Immunology
1998
62
41
Measuring and Predicting Prostate Cancer Related Quality of Life Changes Using EPIC for Clinical Practice
Journal of Urology
2014
62
42
ORIGINAL RESEARCH—ENDOCRINOLOGY: Wide Variability in Laboratory Reference Values for Serum Testosterone
Journal of Sexual Medicine
2006
61
43
Role of IL-12 in the Induction and Potentiation of IFN-γ in Response to Bacillus Calmette-Guérin
Journal of Immunology
1999
61
44
Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
PLoS ONE
2010
57
45
Measuring patients’ expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy
Urology
2006
55
46
Classics of Urology: A Half Century History of the Most Frequently Cited Articles (1955-2009)
Urology
2010
54
47
Comparing Costs of Robotic, Laparoscopic, and Open Partial Nephrectomy
Journal of Endourology
2013
54
48
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
Journal of Urology
2009
52
49
Influence of Testicular Carcinoma on Ipsilateral Spermatogenesis
Journal of Urology
1992
51
50
Synchronous Adenocarcinoma and Transitional Cell Carcinoma of the Bladder Associated with Augmentation: Case Report And Review of the Literature
Journal of Urology
1993
51
site/software ©
exaly
; All materials licenced under
CC by-SA
.